Propiedad y actividad de insiders de Citius Pharmaceuticals, Inc. (CTXR): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.56 |
| Capitalización | $6M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2025-08-08 | Mazur Leonard L | A-Award | 125,490 | $3.6M |
| 2025-08-08 | Mazur Leonard L | A-Award | 89,388 | $1.7M |
| 2025-08-08 | Mazur Leonard L | D-Return | 89,388 | $1.7M |
| 2025-08-08 | Mazur Leonard L | D-Return | 125,490 | $3.6M |
| 2025-08-08 | HOLUBIAK MYRON Z | A-Award | 31,373 | $902K |
| 2025-08-08 | HOLUBIAK MYRON Z | A-Award | 22,344 | $430K |
| 2025-08-08 | HOLUBIAK MYRON Z | D-Return | 31,373 | $902K |
| 2025-08-08 | HOLUBIAK MYRON Z | D-Return | 22,344 | $430K |
| 2024-11-07 | Webb Carol | A-Award | 125,000 | $48K |
| 2024-11-07 | Smith Robert Joseph | A-Award | 125,000 | $48K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $294351 | $3.2M | $9.2M | $7.9M | $13.9M | $70.1M | $41.7M | $26.5M | $3.3M | $4.3M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | $818343 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $8.3M | $22.3M |
| Activos Corrientes | $892835 | $3.4M | $10.1M | $7.9M | $14.0M | $72.8M | $44.6M | $34.4M | $14.2M | $27.9M |
| Inmovilizado Material | $3742 | $3236 | $1483 | $590 | $987781 | $829851 | $650174 | $455858 | $246247 | $818694 |
| Fondo de Comercio | $1.6M | $1.6M | $1.6M | $1.6M | $9.3M | $9.3M | $9.3M | $9.3M | $9.3M | $9.3M |
| Activos Intangibles | $19.4M | $19.4M | $19.4M | $19.4M | $19.4M | $59.4M | $59.4M | $59.4M | $92.8M | $92.8M |
| Activos Totales | $22.0M | $24.4M | $31.1M | $29.0M | $43.8M | $142.4M | $114.0M | $103.6M | $116.7M | $130.9M |
| Cuentas por Pagar | $909156 | $602431 | $1.6M | $2.7M | $1.9M | $1.3M | $1.2M | $2.9M | $4.9M | $13.7M |
| Deuda a Corto | $672970 | $172970 | $172970 | $172970 | $172970 | $177237 | 0 | 0 | 0 | $1.0M |
| Pasivos Corrientes | $5.2M | $2.5M | $3.2M | $4.6M | $4.1M | $4.0M | $4.5M | $5.8M | $35.8M | $44.9M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $164583 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $5.2M | $2.5M | $3.2M | $4.6M | $10.1M | $9.6M | $10.6M | $12.2M | $42.5M | $53.4M |
| Reservas | -$17.3M | -$27.7M | -$40.3M | -$55.8M | -$70.6M | -$96.0M | -$129.7M | -$162.2M | -$201.4M | -$238.8M |
| Patrimonio Neto | $16.8M | $21.9M | $27.9M | $24.4M | $33.7M | $132.2M | $102.8M | $90.8M | $70.1M | $67.6M |
| Deuda Total | $672970 | $172970 | $172970 | $172970 | $1.4M | $855471 | $678234 | $481245 | $262865 | $1.8M |
| Deuda Neta | $378619 | -$3.0M | -$9.0M | -$7.7M | -$12.5M | -$69.2M | -$41.0M | -$26.0M | -$3.0M | -$2.4M |
| Capital Circulante | -$4.3M | $955189 | $6.9M | $3.3M | $9.9M | $68.8M | $40.0M | $28.6M | -$21.6M | -$17.0M |
Salud financiera
| Deuda / Patrimonio | 0.11 |
| Ratio corriente | 0.84 |
Rentabilidad
| Rentabilidad sobre capital | -67.15% |
| Rentabilidad sobre capital invertido | -67.62% |
| Rentabilidad sobre activos | -32.53% |
| Margen bruto | 19.97% |
| Margen operativo | -863.92% |
| Margen neto | -651.27% |
Empresas relacionadas: ADTX · APLM · ATHA · CRIS · DARE · FBLG · ICU
Explorar sector: Healthcare · Biotechnology
Más secciones de CTXR: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones